Nagasaki University Collaborates with NEC OncoImmunity
Monday, August 21, 2023
Nagasaki University and NEC OncoImmunity have announced collaboration focused on leveraging NOI's cutting-edge AI platform to develop universal vaccines capable of addressing the challenges posed by highly pathogenic and tropical infectious diseases.
The collaboration between NOI and Nagasaki University is driven by the shared objective of harnessing the capabilities of advanced AI technology to refine vaccine designs. The ultimate goal is to create vaccines that offer broad and universal protection against specific pathogen families that are prevalent in tropical regions.
Under the scope of the collaboration, NOI's AI technology will be deployed to create vaccines that target both T cell and B cell immune responses. By combining Nagasaki University's tropical medicine expertise with NEC's advanced AI technology, substantial progress in global vaccine development can be achieved for improved public health.
The collaboration aims to showcase interdisciplinary research at the intersection of computer technology and Tropical Medicine. This partnership holds the potential to substantially advance vaccine development efforts.
